,outcome,arm 1,arm 2,comparative statistic,95% CI,p-value,note
0,intervention,doxorubicin,,,,,
0,Overall risk of cardiotoxicity,significantly higher,NR,HR=3.16,1.58-6.31,P<0.001,NR
